Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.

  • Author(s): Tran, Tiffany M
  • Philipp, Julia
  • Bassi, Jaspal Singh
  • Nibber, Neha
  • Draper, Jolene M
  • Lin, Tasha L
  • Palanichamy, Jayanth Kumar
  • Jaiswal, Amit Kumar
  • Silva, Oscar
  • Paing, May
  • King, Jennifer
  • Katzman, Sol
  • Sanford, Jeremy R
  • Rao, Dinesh S
  • et al.

Published Web Location

http://doi.org/10.1038/s41375-021-01346-7
No data is associated with this publication.
Abstract

Despite recent advances in therapeutic approaches, patients with MLL-rearranged leukemia still have poor outcomes. Here, we find that the RNA-binding protein IGF2BP3, which is overexpressed in MLL-translocated leukemia, strongly amplifies MLL-Af4-mediated leukemogenesis. Deletion of Igf2bp3 significantly increases the survival of mice with MLL-Af4-driven leukemia and greatly attenuates disease, with a minimal impact on baseline hematopoiesis. At the cellular level, MLL-Af4 leukemia-initiating cells require Igf2bp3 for their function in leukemogenesis. At the molecular level, IGF2BP3 regulates a complex posttranscriptional operon governing leukemia cell survival and proliferation. IGF2BP3-targeted mRNA transcripts include important MLL-Af4-induced genes, such as those in the Hoxa locus, and the Ras signaling pathway. Targeting of transcripts by IGF2BP3 regulates both steady-state mRNA levels and, unexpectedly, pre-mRNA splicing. Together, our findings show that IGF2BP3 represents an attractive therapeutic target in this disease, providing important insights into mechanisms of posttranscriptional regulation in leukemia.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item